California-based Claret Medical enrolls the final patient in a clinical trial evaluating its Sentinel cerebral protection system for capturing and removing debris dislodged during TAVI procedures.
Claret Medical announced this week that it enrolled the final patient in a U.S. clinical trial as it chases FDA approval for its Sentinel cerebral protection device.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1ptXjzP
Cap comentari:
Publica un comentari a l'entrada